Monogram Orthopedics

Overview

Deal Terms

Company Profile

Deal Summary

Financials

Funding History

Logos provided by Clearbit

Monogram Orthopedics

Platform

Dealmaker Securities

Start Date

07/15/2022

Close Date

11/21/2022

Min. Goal

$100,000

Max. Goal

$5,000,000

Min. Investment

$500

Security Type

Equity - Preferred

Series

Series B

SEC Filing Type

RegCF    

Price Per Share

$10.01

Pre-Money Valuation

$155,000,000

Venture Capital Investors:

Knockout Capital

Logos provided by Clearbit

Monogram Orthopedics

Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Low

Capital Intensity

High

Location

Austin, Texas

Business Type

Growth

Company Website

Monogram Orthopedics, with a valuation of $155 million, is raising funds on DealMaker Securities. The company is developing a product solution architecture to allow the personalization of orthopedic implants. Monogram Orthopaedics uses 3D printing and robotics through automated digital image analysis algorithms. The Monogram Knee System has won FDA approval and is solving real problems by revolutionizing joint replacement technology. Dr. Douglas Unis founded Monogram Orthopaedics in 2016. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development.

Summary Profit and Loss Statement

	Most Recent Year	Prior Year
Revenue	$628,246	$0
COGS	$458,675	$0
Tax	$0	$0
Net Income	$-11,814,968	$-9,068,006

Summary Balance Sheet

	Most Recent Year	Prior Year
Cash	$5,535,710	$5,586,748
Accounts Receivable	$0	$0
Total Assets	$8,715,366	$8,115,888
Short-Term Debt	$0	$0
Long-Term Debt	$0	$0
Total Liabilities	$0	$0

Financials as of: 07/15/2022

Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name	Close Date	Platform	Valuation/Cap	Total Raised	Security Type	Status	Reg Type
Monogram Orthopedics	03/01/2024	Self Managed	$246,000,000	$0	Equity - Common	Active	RegA+
Monogram Orthopedics	11/21/2022	Dealmaker Securities	$155,000,000	$0	Equity - Preferred	Funded	RegCF
Monogram Orthopaedics	02/18/2022	StartEngine	$89,000,000	$23,648,853	Equity - Preferred	Funded	RegA+
Monogram Orthopaedics	01/16/2021	StartEngine	$89,900,000	$2,965,501	Equity - Preferred	Funded	Test the Waters / RegA+
Monogram Orthopaedics	03/31/2020	SeedInvest	$21,250,000	$14,588,668	Equity - Preferred	Funded	RegA+

Create a free account today to gain access to KingsCrowd analytics.

Higher precision and faster surgeries. That’s the name of the game with Monogram.

At first glance, this may seem too futuristic (and borderline impossible).  

I’m here to tell you that Monogram has nearly done it. The company is conducting live surgical demonstrations of its robot for the orthopedic community and is gearing up for FDA submission.  

Once the company’s robot is approved by the FDA, Monogram will launch its first-generation knee offering with generic implants. Once this has been successfully rolled out to hospitals, the company will release its second generation of implants: 3D-printed implants that closely match a patient’s anatomy and stand to disrupt this space in a major way.  

Upgrade to view full report